(Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 24, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to ______________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Commission File Number: 001-39411 Vital Farms, Inc. (Exact name of registrant as specified in its charter) Delaware 27-04 ...

Vital Farms, Inc. (NASDAQ:VITL) Q2 2023 Earnings Conference Call August 3, 2023 8:30 AM ET Company Participants Matthew Siler - VP, IR Russell Diez-Canseco - President and CEO Thilo Wrede - CFO Peter Pappas - Chief Sales Officer Conference Call Participants Pamela Kaufman - Morgan Stanley Cody Ross - UBS Matt McGinley - Needham Matt Smith – Stifel Robert Dickerson - Jefferies Ben Klieve - Lake Street Capital Markets Robert Moskow - TD Cowen Operator Good day, and thank you for standing by. Welcome to the Vi ...

VITAL FARMS, INC. (NASDAQ: VITL) August 2023 Corporate Presentation 2 REPORTING DISCLAIMER Non-GAAP Financial Measures This presentation contains, in addition to historical information, certain forward-looking statements, as defined in Private Securities Litigation Reform Act of 1995, that are based on our current assumptions, expectations and projections about future performance and events and relate to, among other matters, our future financial performance, our business strategy, industry and market trend ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 25, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to ______________ Commission File Number: 001-39411 Vital Farms, Inc. (Exact name of registrant as specified in its charter) Delaware 27-0496985 ...

Vital Farms, Inc. (NASDAQ:VITL) Q1 2023 Results Conference Call May 4, 2023 8:30 AM ET Company Participants Matt Siler - VP, IR Russell Diez-Canseco - President and CEO Thilo Wrede - CFO Kathryn McKeon - Chief Marketing Officer Conference Call Participants Adam Samuelson - Goldman Sachs Pamela Kaufman - Morgan Stanley Cody Ross - UBS Matt McGinley - Needham Robert Dickerson - Jefferies Matt Smith - Stifel Ben Klieve - Lake Street Capital Markets Matt Siler - VP, IR Operator Good day, and thank you for stand ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 26, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to ______________ Commission File Number: 001-39411 Vital Farms, Inc. (Exact name of registrant as specified in its charter) Delaware 27-049698 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 25, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to ______________ Commission File Number: 001-39411 Vital Farms, Inc. (Exact name of registrant as specified in its charter) Delaware 27-0496985 (St ...

VITAL FARMS, INC. (NASDAQ: VITL) March 9, 2023 Corporate Presentation t your and with a wall a lines of . REPORTING DISCLAIMER Non-GAAP Financial Measures "Adjusted EBITDA Margin" is defined as Adjusted EBITDA divided by net revenues. This presentation contains, in addition to historical information, certain forward-looking statements, as defined in Private Securities Litigation Reform Act of 1995, that are based on our current assumptions, expectations and projections about future performance and events an ...

VITAL FARMS, INC. (NASDAQ: VITL) November 3, 2022 Corporate Presentation REPORTING DISCLAIMER This presentation contains, in addition to historical information, certain forward-looking statements, as defined in Private Securities Litigation Reform Act of 1995, that are based on our current assumptions, expectations and projections about future performance and events and relate to, among other matters, our future financial performance, our business strategy, industry and market trends, future expectations co ...

Vital Farms, Inc. (NASDAQ:VITL) Q3 2022 Earnings Conference Call November 3, 2022 8:30 AM ET Company Participants Matt Siler - Vice President, Investor Relations Russell Diez-Canseco - President and CEO Bo Meissner - Chief Financial Officer Kathryn McKeon - Chief Marketing Officer Conference Call Participants Adam Samuelson - Goldman Sachs Pamela Kaufman - Morgan Stanley Cody Ross - UBS Brian Holland - Cowen and Company Robert Dickerson - Jefferies Chris Growe - Stifel Operator Good day and thank you for st ...